Ibogaine Development
Advancing the scientific understanding and responsible development of ibogaine and related research materials through rigorous characterization, quality standards, and collaborative research.

Pipeline
Reset Health is advancing natural-product science that begins with Tabernanthe iboga and extends toward a broader vision of botanical discovery, rooted in Gabon and pursued through responsible research and global collaboration.
Focus
Our work is organized around three areas of scientific focus.
Advancing the scientific understanding and responsible development of ibogaine and related research materials through rigorous characterization, quality standards, and collaborative research.
Investigating scientifically characterized botanical and alkaloid materials to support reproducible research and expand understanding of the broader chemistry of Tabernanthe iboga.
Exploring the broader scientific potential of natural products and biodiversity, beginning with Gabon, through responsible research and scientific collaboration.
Specific programs, development stages, and research collaborations will be disclosed as appropriate milestones are reached.
Gabon
Our work begins in Gabon, the native home of Tabernanthe iboga, combining scientific rigor, responsible sourcing, and international collaboration.
Our scientific approach emphasizes analytical characterization, reproducibility, and evidence-based research.
Traceable, sustainable botanical sourcing designed to protect long-term supply and ecological value.
Strengthening scientific and technical capability in Gabon as part of a durable natural-products research ecosystem.
Pursuing development models designed to create scientific, institutional, and economic value within Gabon.
Partnership
Reset Health welcomes collaboration with researchers, scientific institutions, and mission-aligned investors.
For universities, scientific institutions, and translational research groups.
For organizations experienced in botanical-product characterization and pharmaceutical development.
For investors seeking exposure to a natural-products biotechnology platform.
Select the area most relevant to your organization and our team will route your inquiry appropriately.
Reset Health's research and development activities are investigational and are not approved for commercial therapeutic use by the U.S. Food and Drug Administration or other regulatory authorities. Information on this page is for corporate and scientific communication purposes only and is not medical advice.